Ernexa Therapeutics ERNA
NASDAQ ERNA
$1.93 -0.08 (-3.98%)
At close: Nov 11, 2026 · 4:00 PM EST

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026)

Updated

Ernexa Therapeutics (ERNA) posted Goodwill impairment charges of $2.04 million for Q1 2026.

Analysis

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026) Analysis & Trends

For FY2020, Ernexa Therapeutics' Goodwill impairment charges came in at $662,000.

  • In prior years, Ernexa Therapeutics' Goodwill impairment charges was $261,000 in FY2018.
  • The Q1 2026 figure stands as the lowest quarterly Goodwill impairment charges since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ernexa Therapeutics 3.31 Mn -18.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.04 Mn
Mar 31, 2020 662,000.00
API Access

Ernexa Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ERNA&period=max&api_key=YOUR_API_KEY